ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,048,000 | -9.1% | 164,700 | 0.0% | 0.06% | +13.2% |
| Q3 2016 | $2,254,000 | +21.9% | 164,700 | -34.2% | 0.05% | +15.2% |
| Q2 2016 | $1,849,000 | +15.6% | 250,300 | 0.0% | 0.05% | +27.8% |
| Q1 2016 | $1,599,000 | +128.1% | 250,300 | +122.9% | 0.04% | +140.0% |
| Q4 2015 | $701,000 | +7.0% | 112,300 | 0.0% | 0.02% | -16.7% |
| Q3 2015 | $655,000 | -29.4% | 112,300 | 0.0% | 0.02% | -5.3% |
| Q2 2015 | $928,000 | +0.3% | 112,300 | 0.0% | 0.02% | +5.6% |
| Q1 2015 | $925,000 | +20.0% | 112,300 | 0.0% | 0.02% | +20.0% |
| Q4 2014 | $771,000 | +27.2% | 112,300 | 0.0% | 0.02% | +25.0% |
| Q3 2014 | $606,000 | -15.2% | 112,300 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $715,000 | -21.0% | 112,300 | 0.0% | 0.01% | -25.0% |
| Q1 2014 | $905,000 | +18.3% | 112,300 | 0.0% | 0.02% | +23.1% |
| Q4 2013 | $765,000 | -20.5% | 112,300 | +114.7% | 0.01% | -27.8% |
| Q3 2013 | $962,000 | +5.3% | 52,300 | 0.0% | 0.02% | +5.9% |
| Q2 2013 | $914,000 | – | 52,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |